Ph.D., Chief Scientific Officer and Co-Founder, Karius
Tim Blauwkamp is the Chief Scientific Officer and co-founder of Karius. Prior to Karius, he led research and lab operations for the long-reads DNA sequencing startup Moleculo, until its acquisition by Illumina. Tim received his PhD in Biochemistry from the University of Michigan for studies of gene transcription networks in bacteria. He completed his postdoctoral research at Stanford University which focused on signaling mechanisms that influence early development and stem cell biology.
Microbial Profiling Showcase: Karius
Karius is a life sciences company focused on transforming infectious disease diagnostics with genomics.
Infectious Disease Identification Using Cell-Free DNA Sequencing
Thousands of pathogens can infect humans, but only a fraction are readily identifiable with existing diagnostic methods. Karius uses microbial cell-free DNA sequencing to detect bacteria, fungi, DNA viruses, or eukaryotic pathogens causing disease throughout the body.